相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mesenchymal Stem Cell-Based Therapy as a New Approach for the Treatment of Systemic Sclerosis
Xiufen Zhuang et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2023)
Regulatory B Cells Contribute to the Clinical Response After Bone Marrow-Derived Mesenchymal Stromal Cell Infusion in Patients With Systemic Sclerosis
Severine Loisel et al.
STEM CELLS TRANSLATIONAL MEDICINE (2023)
Established and Emerging Treatments of Skin GvHD
Cornelia S. Link-Rachner et al.
FRONTIERS IN IMMUNOLOGY (2022)
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study
Dominique Farge et al.
LANCET RHEUMATOLOGY (2022)
LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma
Chamutal Gur et al.
CELL (2022)
Efficacy and safety of mesenchymal stem cells in the treatment of systemic sclerosis: a systematic review and meta-analysis
Jiehan Cui et al.
STEM CELL RESEARCH & THERAPY (2022)
Combination of Dexamethasone and Tofacitinib Reduces Xenogeneic MSC-Induced Immune Responses in a Mouse Model of Alzheimer's Disease
Na Kyung Lee et al.
BIOMEDICINES (2022)
Application of ADSCs and their Exosomes in Scar Prevention
Cong Li et al.
STEM CELL REVIEWS AND REPORTS (2022)
Mesenchymal stromal cells for systemic sclerosis treatment
Dominique Farge et al.
AUTOIMMUNITY REVIEWS (2021)
Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA
Yingling Zu et al.
SCIENTIFIC REPORTS (2021)
Strategies to address mesenchymal stem/stromal cell heterogeneity in immunomodulatory profiles to improve cell-based therapies
Celia M. Dunn et al.
ACTA BIOMATERIALIA (2021)
Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p
Pauline Rozier et al.
JOURNAL OF AUTOIMMUNITY (2021)
Antifibrotic effects and mechanisms of mesenchymal stem cell-derived exosomes in a systemic sclerosis mouse model: Possible contribution of miR-196b-5p
Hritu Baral et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2021)
BMSC-derived extracellular vesicles intervened the pathogenic changes of scleroderma in mice through miRNAs
Jiahui Jin et al.
STEM CELL RESEARCH & THERAPY (2021)
Immunosuppressant Drugs Mitigate Immune Responses Generated by Human Mesenchymal Stem Cells Transplanted into the Mouse Parenchyma
Jung Won Hwang et al.
CELL TRANSPLANTATION (2021)
Anti-fibrotic mechanisms of exogenously-expanded mesenchymal stromal cells for fibrotic diseases
Jason S. Rockel et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)
Adipose-derived stromal/stem cells successfully attenuate the fibrosis of scleroderma mouse models
Ai Okamura et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2020)
CCL2 and CXCL12 Derived from Mesenchymal Stromal Cells Cooperatively Polarize IL-10+Tissue Macrophages to Mitigate Gut Injury
Jayeeta Giri et al.
CELL REPORTS (2020)
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Olaf Penack et al.
Lancet Haematology (2020)
Extracellular vesicles derived from mesenchymal stem cells prevent skin fibrosis in the cGVHD mouse model by suppressing the activation of macrophages and B cells immune response
Liyan Guo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Treatment of chronicGvHDwith mesenchymal stromal cells induces durable responses: A phaseIIstudy
Erik Boberg et al.
STEM CELLS TRANSLATIONAL MEDICINE (2020)
Current immunosuppressive and antifibrotic therapies of systemic sclerosis and emerging therapeutic strategies
Benedict Fallet et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2020)
How to influence the mesenchymal stem cells fate? Emerging role of ectoenzymes metabolizing nucleotides
Katarzyna Roszek et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
N. C. Nadia de Cassia Noronha et al.
STEM CELL RESEARCH & THERAPY (2019)
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling
Paola Di Benedetto et al.
SCIENTIFIC REPORTS (2019)
Bone Marrow-Derived and Adipose-Derived Mesenchymal Stem Cell Therapy in Primary Knee Osteoarthritis: A Narrative Review
Prathap Jayaram et al.
PM&R (2019)
Cyclosporine A promotes the therapeutic effect of mesenchymal stem cells on transplantation reaction
Michaela Hajkova et al.
CLINICAL SCIENCE (2019)
The influence of hypoxia and IFN-γ on the proteome and metabolome of therapeutic mesenchymal stem cells
Holly M. Wobma et al.
BIOMATERIALS (2018)
The effect of clinically relevant doses of immunosuppressive drugs on human mesenchymal stem cells
Eliska Javorkova et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
CsA attenuates compression-induced nucleus pulposus mesenchymal stem cells apoptosis via alleviating mitochondrial dysfunction and oxidative stress
Zhiliang Li et al.
LIFE SCIENCES (2018)
Discovery and development of sGC stimulators for the treatment of pulmonary hypertension and rare diseases
Peter Sandner et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2018)
Supportive Use of Adipose-Derived Stem Cells in Cell-Assisted Lipotransfer for Localized Scleroderma
Bo Chen et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2018)
Elevated Expression of Dkk-1 by Glucocorticoid Treatment Impairs Bone Regenerative Capacity of Adipose Tissue-Derived Mesenchymal Stem Cells
Toshiki Kato et al.
STEM CELLS AND DEVELOPMENT (2018)
Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-gamma
Dae Seong Kim et al.
EBIOMEDICINE (2018)
Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges
Juliette Peltzer et al.
FRONTIERS IN IMMUNOLOGY (2018)
A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD
Peilong Lai et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Fibrosis Development in HOCI-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells
Alexandre T. J. Maria et al.
FRONTIERS IN IMMUNOLOGY (2018)
iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic Sclerosis
Alexandre T. J. Maria et al.
FRONTIERS IN IMMUNOLOGY (2018)
Clinical Application of Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapeutics for Inflammatory Lung Diseases
Yu Fujita et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy
Paola Di Benedetto et al.
ARTHRITIS RESEARCH & THERAPY (2018)
A local application of mesenchymal stem cells and cyclosporine A attenuates immune response by a switch in macrophage phenotype
Michaela Hajkova et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2017)
Mesenchymal Stem Cells Attenuate the Adverse Effects of Immunosuppressive Drugs on Distinct T Cell Subopulations
Michaela Hajkova et al.
STEM CELL REVIEWS AND REPORTS (2017)
Mesenchymal Stem Cells Attenuate the Adverse Effects of Immunosuppressive Drugs on Distinct T Cell Subopulations
Michaela Hajkova et al.
STEM CELL REVIEWS AND REPORTS (2017)
Bone Marrow-Derived Mesenchymal Stem Cells Expressing Thioredoxin 1 Attenuate Bleomycin-Induced Skin Fibrosis and Oxidative Stress in Scleroderma
Miao Jiang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus-Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration in a Mouse Model
Ji-Young Lim et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
R. Knobler et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effect of Mesenchymal Stromal Cells on T Cells in a Septic Context: Immunosuppression or Immunostimulation?
Sebastien Le Burel et al.
STEM CELLS AND DEVELOPMENT (2017)
Adipose tissue-derived stem cells ameliorates dermal fibrosis in mouse models of scleroderma
Wei Chen et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2017)
Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
Debomita Chakraborty et al.
NATURE COMMUNICATIONS (2017)
Characteristics of human adipose derived stem cells in scleroderma in comparison to sex and age matched normal controls: implications for regenerative medicine
Michelle Griffin et al.
STEM CELL RESEARCH & THERAPY (2017)
Bone Marrow, Adipose, and Lung Tissue-Derived Murine Mesenchymal Stromal Cells Release Different Mediators and Differentially Affect Airway and Lung Parenchyma in Experimental Asthma
Soraia C. Abreu et al.
STEM CELLS TRANSLATIONAL MEDICINE (2017)
Serum-Mediated Oxidative Stress from Systemic Sclerosis Patients Affects Mesenchymal Stem Cell Function
Guillaume Fonteneau et al.
FRONTIERS IN IMMUNOLOGY (2017)
Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis
Jingang Huang et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis
Huayong Zhang et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Role of the microRNA-29 family in fibrotic skin diseases
Duygu Harmanci et al.
BIOMEDICAL REPORTS (2017)
Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis
Chider Chen et al.
CELL RESEARCH (2017)
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease
Kenneth R. Cooke et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Mesenchymal Stromal Cells Disrupt mTOR-Signaling and Aerobic Glycolysis During T-Cell Activation
Martin Boettcher et al.
STEM CELLS (2016)
Searching for a good model for systemic sclerosis: the molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis
Paola Cipriani et al.
ARCHIVES OF MEDICAL SCIENCE (2016)
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
Jacques Galipeau et al.
CYTOTHERAPY (2016)
Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis
Alexandre T. J. Maria et al.
JOURNAL OF AUTOIMMUNITY (2016)
Dendritic cells maintain dermal adipose-derived stromal cells in skin fibrosis
Jennifer J. Chia et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Allogeneic clonal mesenchymal stem cell therapy for refractory graft-versus-host disease to standard treatment: a phase I study
Hyeon Gyu Yi et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2016)
Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation
Li Wang et al.
STEM CELLS AND DEVELOPMENT (2016)
Mechanisms of mesenchymal stem/stromal cell function
Jeffrey L. Spees et al.
STEM CELL RESEARCH & THERAPY (2016)
Antifibrotic, Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl-Induced Systemic Sclerosis
Alexandre T. J. Maria et al.
ARTHRITIS & RHEUMATOLOGY (2016)
A Clinical Indications Prediction Scale Based on TWIST1 for Human Mesenchymal Stem Cells
Siddaraju V. Boregowda et al.
EBIOMEDICINE (2016)
Immunomodulation by mesenchymal stem cells: Interplay between mesenchymal stem cells and regulatory lymphocytes
Oscar Ka-Fai Ma et al.
WORLD JOURNAL OF STEM CELLS (2016)
MicroRNAs in fibrosis: opportunities and challenges
Steven O'Reilly
ARTHRITIS RESEARCH & THERAPY (2016)
Dexamethasone and Azathioprine Promote Cytoskeletal Changes and Affect Mesenchymal Stem Cell Migratory Behavior
Natalia Schneider et al.
PLOS ONE (2015)
Update on mesenchymal stem cell-based therapy in lupus and scleroderma
Audrey Cras et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy
Chun-yu Li et al.
STEM CELL RESEARCH & THERAPY (2015)
Effects of immunosuppressive drugs on viability and susceptibility of adipose- and bone marrow-derived mesenchymal stem cells
Wakako Tsuji et al.
FRONTIERS IN IMMUNOLOGY (2015)
Systemic sclerosis
Yannick Allanore et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial
Brigitte Granel et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Glucocorticoids induce autophagy in rat bone marrow mesenchymal stem cells
Long Wang et al.
MOLECULAR MEDICINE REPORTS (2015)
Influence of glucocorticoids on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells
Da-An Zhou et al.
BMC MUSCULOSKELETAL DISORDERS (2014)
Fibrosis-a lethal component of systemic sclerosis
Yuen Yee Ho et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
MiR-29a Reduces TIMP-1 Production by Dermal Fibroblasts via Targeting TGF-β Activated Kinase 1 Binding Protein 1, Implications for Systemic Sclerosis
Marzena Ciechomska et al.
PLOS ONE (2014)
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features
Paola Cipriani et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice
Yan Wu et al.
INTERNATIONAL WOUND JOURNAL (2014)
The interaction between mesenchymal stem cells and steroids during inflammation
X. Chen et al.
CELL DEATH & DISEASE (2014)
New fat-derived products for treating skin-induced lesions of scleroderma in nude mice
Nicolas Serratrice et al.
STEM CELL RESEARCH & THERAPY (2014)
Osteogenic potential: Comparison between bone marrow and adipose-derived mesenchymal stem cells
Han-Tsung Liao
World Journal of Stem Cells (2014)
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine
Paola Cipriani et al.
ANGIOGENESIS (2013)
Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: Role of secretome and exosomes
Marie Maumus et al.
BIOCHIMIE (2013)
Human Adipose-Derived Stromal Cells for Cell-Based Therapies in the Treatment of Systemic Sclerosis
Nicolo Scuderi et al.
CELL TRANSPLANTATION (2013)
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy
P. Cipriani et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Expression of transforming growth factor beta receptor II in mesenchymal stem cells from systemic sclerosis patients
Valerie Vanneaux et al.
BMJ OPEN (2013)
Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine
Matthew B. Murphy et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis
Kentaro Akiyama et al.
CELL STEM CELL (2012)
TGF-β-Mediated Downregulation of MicroRNA-196a Contributes to the Constitutive Upregulated Type I Collagen Expression in Scleroderma Dermal Fibroblasts
Noritoshi Honda et al.
JOURNAL OF IMMUNOLOGY (2012)
Mesenchymal Stem Cells Repress Th17 Molecular Program through the PD-1 Pathway
Patricia Luz-Crawford et al.
PLOS ONE (2012)
Alkylating chemotherapeutic agents cyclophosphamide and melphalan cause functional injury to human bone marrow-derived mesenchymal stem cells
Kevin Kemp et al.
ANNALS OF HEMATOLOGY (2011)
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro
Serena Guiducci et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases
Gernot Keyszer et al.
ARTHRITIS AND RHEUMATISM (2011)
Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy
Yuka Ikegame et al.
CYTOTHERAPY (2011)
Human adipose tissue-derived mesenchymal stem cells facilitate the immunosuppressive effect of cyclosporin A on T lymphocytes through Jagged-1-mediated inhibition of NF-κB signaling
Dan Shi et al.
EXPERIMENTAL HEMATOLOGY (2011)
Circulating miR-29a levels in patients with scleroderma spectrum disorder
Yoshio Kawashita et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2011)
Nitric oxide regulates the repair of injured skeletal muscle
Lidiane Isabel Filippin et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2011)
Autologous Mesenchymal Stem Cells Foster Revascularization of Ischemic Limbs in Systemic Sclerosis A Case Report
Serena Guiducci et al.
ANNALS OF INTERNAL MEDICINE (2010)
Efficacy of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Sclerodermatous Chronic Graft-versus-Host Disease: Clinical Report
Hong Zhou et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis
Nobuyo Higashi-Kuwata et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Role of Growth Factors in the Pathogenesis of Tissue Fibrosis in Systemic Sclerosis
Sergio A. Jimenez et al.
CURRENT RHEUMATOLOGY REVIEWS (2010)
Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cells
K. English et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Selective Oxidation of DNA Topoisomerase 1 Induces Systemic Sclerosis in the Mouse
Amelie Servettaz et al.
JOURNAL OF IMMUNOLOGY (2009)
Feasibility of NIH consensus criteria for chronic graft-versus-host disease
B-S Cho et al.
LEUKEMIA (2009)
Genzyme backs Osiris, despite Prochymal flop
Malorye Allison
NATURE BIOTECHNOLOGY (2009)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
IFN-γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease
David Polchert et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The roles of chemokines in leukocyte recruitment and fibrosis in systemic sclerosis
Minoru Hasegawa et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue
Linyi Peng et al.
STEM CELLS AND DEVELOPMENT (2008)
Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L
M. Christopeit et al.
LEUKEMIA (2008)
Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis
J. Larghero et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity
Mayumi Kusumoto et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2007)
IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells
Karen English et al.
IMMUNOLOGY LETTERS (2007)
Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells - New insight into the pathogenesis of systemic sclerosis
P. Cipriani et al.
ARTHRITIS AND RHEUMATISM (2007)
Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro
C. Bocelli-Tyndall et al.
RHEUMATOLOGY (2007)
Systemic sclerosis: a prototypic multisystem fibrotic disorder
John Varga et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Chronic graft versus host disease
Kristin Baird et al.
CURRENT OPINION IN HEMATOLOGY (2006)
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting
Alma J. Nauta et al.
BLOOD (2006)
Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue
Susanne Kern et al.
STEM CELLS (2006)
Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells
Mauro Krampera et al.
STEM CELLS (2006)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Human adult CD34- progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4
I Von Lüttichau et al.
STEM CELLS AND DEVELOPMENT (2005)
Human mesenchymal stem cells modulate allogeneic immune cell responses
S Aggarwal et al.
BLOOD (2005)
Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis
H Fujii et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2004)
Antifibrotic role of inducible nitric oxide synthase
MG Ferrini et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2002)
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
A Bartholomew et al.
EXPERIMENTAL HEMATOLOGY (2002)
Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis
S Sato et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2001)
分享论文
